Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OPN-15006178Phase 4Not yet recruiting
Phase 4, open-label trial of salvianolic acids injection in brain infarction (5 arms), sponsored by Tianjin University of Traditional Chinese Medicine. Primary endpoints: Plasma drug concentration and Urinary drug concentration. Planned start Apr 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OPN-15006178.